Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov 6;62(45):e202306659.
doi: 10.1002/anie.202306659. Epub 2023 Aug 9.

Preparative Scale Applications of C-H Activation in Medicinal Chemistry

Affiliations
Review

Preparative Scale Applications of C-H Activation in Medicinal Chemistry

Rita de Jesus et al. Angew Chem Int Ed Engl. .

Abstract

C-H activation is an attractive methodology to increase molecular complexity without requiring substrate prefunctionalization. In contrast to well-established cross-coupling methods, C-H activation is less explored on large scales and its use in the production of pharmaceuticals faces substantial hurdles. However, the inherent advantages, such as shorter synthetic routes and simpler starting materials, motivate medicinal chemists and process chemists to overcome these challenges, and exploit C-H activation steps for the synthesis of pharmaceutically relevant compounds. In this review, we will cover examples of drugs/drug candidates where C-H activation has been implemented on a preparative synthetic scale (range between 355 mg and 130 kg). The optimization processes will be described, and each example will be examined in terms of its advantages and disadvantages, providing the reader with an in-depth understanding of the challenges and potential of C-H activation methodologies in the production of pharmaceuticals.

Keywords: Catalysis; C−H Activation; Large Scale Synthesis; Pharmaceuticals; Sustainability.

PubMed Disclaimer

References

    1. None
    1. D. J. Stewart, A. A. Stewart, P. Wheatley-Price, G. Batist, H. M. Kantarjian, J. Schiller, M. Clemons, J.-P. Bradford, L. Gillespie, R. Kurzrock, Cancer Med. 2018, 7, 1824;
    1. R. Jana, H. M. Begam, E. Dinda, Chem. Commun. 2021, 57, 10842.
    1. D. G. Brown, J. Boström, J. Med. Chem. 2016, 59, 4443.
    1. None

Publication types

MeSH terms

Substances

LinkOut - more resources